News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
Behind the Code: Humanizing Data Science at Bristol Myers Squibb
Julie Rytlewski has always loved math and medicine. As a teenager, she taught herself to code, built her own computer and developed a passion for
AAHI lands $18M award from the NIH
Access to Advanced Health Institute, a biotech nonprofit based in Seattle, received an $18 million grant from the National Institutes of Health. The funding will
After tech contraction, WA still has more jobs than job seekers
Washington’s labor market has remained strong amidst national tech layoffs and indicators of a recession. According to the Bureau of Labor Statistics, high hiring rates
Phase Genomics lands $2.5M in fresh funding
Phase Genomics, a Seattle-based biotech company, secured $2.5 million in funding from the National Cancer Institute and the Andy Hill Cancer Research Endowment (CARE) Fund
Top 10 U.S. Biopharma Clusters
Seattle is ranked ninth in GEN’s 2023 rankings for the top 10 biopharma clusters across the country. Over the past year, major biotech moves including
Seattle startups move into growing science cluster in South Lake Union
Dexter Yard, a new, two-tower complex in Seattle, is becoming a home for several biotech companies moving into the space. Outpace Bio, Parse Biosciences and
Sana breaks ground on manufacturing facility in Bothell
Sana Biotechnology Inc., a biotech company based in Seattle, broke ground on its new Bothell manufacturing site recently. The 80,000 square-foot facility, which will provide
Report: Moderna inks large sublease in Seattle
A report from Newmark announced that Cambridge, Massachusetts-headquartered pharmaceutical and biotech giant Moderna will support the Seattle’s market for office space by subleasing 54,350 square
University of Washington spinout Neoleukin Therapeutics merging with New York City startup
Seattle-based biotech company Neoleukin Therapeutics announced that it will merge with Neurogene, a New York-based gene therapy organization. Finalization of the merger is expected to
A-Alpha Bio, a biotech startup that measures and predicts protein interactions, raises $22.4M
A-Alpha Bio, a Seattle-based biotech company, raised $22.4 million to fund a machine learning project that will fuel its work to create therapeutic proteins. The
Report ranks Seattle No. 2 in overall ‘Tech Talent’ even as hiring slows across industry
CBRE’s 2023 Scoring Tech Talent report declared Seattle as the second-best tech market in North America despite the industry’s ongoing layoffs. Seattle also ranked second
Listen: How Lundbeck’s Bothell Team Turns Ideas into Reality
When people think of R&D, it’s easy to imagine the research, but the other half of that equation — development — is just as critical